# ClinicalTrials.gov record NCT01680653

> PeptideScanner retained ClinicalTrials.gov record NCT01680653 at 2026-07-30T21:12:47.409Z. Its registry update date was 2018-03-05, and PeptideScanner's reviewed identity mapping was glucagon.

- Evidence object: `story:clinicaltrials-gov-nct01680653-glucagon:v1`
- Evidence domain: Clinical trials
- Date in source: 2018-03-05
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01680653-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01680653-glucagon-v1.json
- Content SHA-256: `d059ac11a225e0830a4590b69d60bbc91ac40e4fce7a5ae4a253fdf4c61dff4c`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01680653 ([`ctg-observation-nct01680653-2018-03-05-e28972a2d47a`](#source-ctg-observation-nct01680653-2018-03-05-e28972a2d47a))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01680653 at 2026-07-30T21:12:47.409Z. Its registry update date was 2018-03-05, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct01680653-2018-03-05-e28972a2d47a`](#source-ctg-observation-nct01680653-2018-03-05-e28972a2d47a))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01680653 at 2026-07-30T21:12:47.409Z. Its registry update date was 2018-03-05, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct01680653-2018-03-05-e28972a2d47a`](#source-ctg-observation-nct01680653-2018-03-05-e28972a2d47a))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01680653-2018-03-05-e28972a2d47a`](#source-ctg-observation-nct01680653-2018-03-05-e28972a2d47a))

## Sources

<a id="source-ctg-observation-nct01680653-2018-03-05-e28972a2d47a"></a>
- **ClinicalTrials.gov record NCT01680653 · retained source version 2018-03-05:e28972a2d47af0b174b34ababbb1617f0f82e4b113cdb367e89c8cd37d8d7f42** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01680653) (`ctg-observation-nct01680653-2018-03-05-e28972a2d47a`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01680653." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01680653-glucagon-v1.json SHA-256: d059ac11a225e0830a4590b69d60bbc91ac40e4fce7a5ae4a253fdf4c61dff4c.